Minal Garg
Overview
Explore the profile of Minal Garg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddhartha R, Singhai A, Goel A, Garg M
Biomarkers
. 2024 Dec;
30(1):23-36.
PMID: 39668728
Background: Endoglin/CD105-microvessel density (CD105-MVD) is identified as one of the most potential methods for semi-quantification of angiogenesis in human cancer tissues. Present study aimed to examine the diagnosticand prognostic value...
2.
Niharika , Garg M
Expert Rev Mol Med
. 2024 Oct;
26:e23.
PMID: 39375840
Complex tumour ecosystem comprising tumour cells and its associated tumour microenvironment (TME) constantly influence the tumoural behaviour and ultimately impact therapy failure, disease progression, recurrence and poor overall survival of...
3.
Siddhartha R, Goel A, Singhai A, Garg M
Biochem Genet
. 2024 Sep;
PMID: 39311994
Matrix metalloproteinases (MMPs) are involved in extracellular matrix (ECM) remodeling during embryogenesis, wound healing and tumor development. Aberrant expressions and activation of MMP-2 and MMP-9 are examined as one of...
4.
Siddhartha R, Garg M
Mol Cancer Ther
. 2023 Mar;
22(3):291-305.
PMID: 36861362
Studying the complex mechanisms of tumorigenesis and examining the interactions of neoplastic cells within tumor ecosystem are critical to explore the possibility of effective cancer treatment modalities. Dynamic tumor ecosystem...
5.
Tripathi K, Maurya N, Goel A, Singhai A, Garg M
Mol Cell Biochem
. 2022 Oct;
478(6):1169-1190.
PMID: 36239855
Mutation or overexpression renders pan-RAS (rat sarcoma) proteins insensitive to inactivation. Activated pan-RAS communicates signal from the cell surface receptor to activate RAS-MAPK/ERK (RAS-mitogen-activated protein kinases/extracellular signal regulated kinases) signaling...
6.
Garg M
Cancer Metastasis Rev
. 2022 Jan;
41(1):131-145.
PMID: 34978017
Strong association of cancer incidence and its progression with mortality highlights the need to decipher the cellular and molecular mechanisms that drive tumor cells to rapidly progress to metastatic disease...
7.
Gupta P, Kumar N, Garg M
Expert Opin Ther Targets
. 2021 Oct;
25(9):787-797.
PMID: 34636265
Introduction: High recurrence rates, frequent surveillance strategies, and current multidisciplinary treatment approaches make urothelial carcinoma of bladder (UCB) one of the most expensive cancers to clinically manage. Recent studies have...
8.
Siddhartha R, Garg M
Toxicol Appl Pharmacol
. 2021 May;
426:115593.
PMID: 34038713
Matrix metalloproteinases (MMPs) are the group of enzymes that belong to the family of zinc dependent endopeptidases. These proteases degrade collagen and other important proteins in extracellular matrix (ECM) and...
9.
Tripathi K, Goel A, Singhai A, Garg M
Mol Biol Rep
. 2021 Feb;
48(3):2183-2199.
PMID: 33620658
Overexpression of normal Ras and its aberrant CpG island methylation in the promoter regions have been shown to direct cells for uncontrolled abnormal growth and bladder tumor formation and therefore,...
10.
Tripathi K, Goel A, Singhai A, Garg M
World J Clin Oncol
. 2020 Sep;
11(8):614-628.
PMID: 32879848
Background: Mutational activation of genes is established as a prognostic factor for the genesis of a constitutively active RAS-mitogen activated protein kinase pathway that leads to cancer. Heterogeneity among the...